A message from the GSIPP President
Dear GSIPP Members
Amit Patel, MD,
I am honored to be elected President of the Georgia Society of Interventional Pain Physicians (GSIPP)! I want to thank our former presidents Dr's Dua, Galan, Giron, Epter, Pollydore, and Gale for providing outstanding leadership over the years. Under their leadership, GSSIP has protected the scope of practice, fought challenges to reimbursement, and advocated for new innovations which has changed our patient’s lives. To say the least I have BIG shoes to fill over the next two years!
I also want to thank the backbone of GSIPP, Tara Morrison, Katie Brown, Karrie Kirwan, and Cathy Jones. This team provides support and is instrumental in setting up our annual meetings. The group has helped execute board recommendations over the years and without them our organization would not be the same. Finally, I would like to thank our lobbyist, Chandler Haydon who has work with legislators in the House and Senate on behalf of GSIPP. Her leadership in that role has been instrumental in putting GSIPP legislative initiatives at the forefront.
The core mission of GSIPP is to promote the development and practice of safe, high quality, cost effective interventional pain management techniques for the diagnosis and treatment of pain.
My goal as President is to propose a 5-point plan which will set a goal and vision for GSIPP to reach over the next two years.
- I want to enhance the value of the GSIPP membership. I believe the way we do this is to create content that is valuable for our members and our patients. The content can include updated changes in local coverage determinations, changes in fee schedules, federal discretionary changes in reimbursement, and creating mentorship opportunities for younger physicians. Our goal should be to increase our membership by 25 percent over the next two years!
- I want GSIPP to be a better partner with our industry vendors. Our industry partners help support our meetings and societies on a yearly basis. Without there sponsorship it would be difficult to hold our robust meetings. Engaging with our industry partners allows our members to learn new innovations and participate in meaningful dialogue surrounding patient outcomes. Strengthening this bond can lead to many synergies for our members in providing superior service to our patients.
- I want to HELP SAVE MONEY. In the past GSIPP has rolled out the Independent Physician Partners. I want to reenergize this component of GSIPP. The interventional pain space in Georgia is highly fragmented which means we have a lot of small to mid-size practices. These practices make up the majority of GSIPP members. Unfortunately, small practices do not have a voice when it comes to payor contracts, group purchasing (GP) and other administrative services. By banding together, we can create a large voice. In the past we have concentrated on payor contract which has deemed to be difficult. I still believe this is the path that we can still explore; however, shifting our focus to group purchasing can help all of our practices when negotiating supply chain expenditure.
- I want to promote diversity and inclusion within GSIPP. I believe we have started to do that at the board level and during our membership drive, but we can do more. When I am talking about inclusion I also mean reaching to potential members in rural area of GA. We want all interventional pain physicians of GA to be members of GSIPP.
- Last and probably most important is our participation of both our time and money is supporting our GSIPP PAC. This PAC has been ESSENTIAL in protecting our SCOPE of practice and REALLY our livelihood. Our advocacy in the past has protected our reimbursement for certain procedures, held our payors accountable and blocked legislation that would harm our field.
In the words of Coretta Scott King
"The greatness of a community is most accurately measured by the compassionate actions of its members." – Coretta Scott King
During these difficult times of COVID19; challenges to our scope of practice, pressures on reimbursements, increase regulatory burdens, we now must band together as an organization to have our voices heard to better serve our community with our core mission. I believe with collaboration, communications, and collegiality, together we can accomplish these goals.
Amit Patel, MD
DEA to Publish Final Rule Rescheduling Hydrocodone Combination Products
AUG 21 (WASHINGTON)–On Friday the U. S. Drug Enforcement Administration (DEA) will publish in the Federal Register the Final Rule moving
hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II, as recommended by the Assistant Secretary for Health of the
U.S. Department of Health and Human Services (HHS) and as supported by the DEA’s own evaluation of relevant data. The Federal Register has made the Final
Rule available for preview on its website today at go.usa.gov/mc8d.
This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. It goes
into effect in 45 days.
Georgia gets an A grade for Pain Policies
We have recently received great news from The Pain and Policy Studies Group at The University of Wisconsin as they have given
Georgia a grade of A with respect to our Great State's Pain Policies. This has been a steady decade of improvement as in 2006
and 2007, Georgia graded in at a D+. GSIPP has led the path to making those improvements by advocating and fighting for our
Prescription Drug Monitoring Program; promoting legislation and increased requirements of our specialty in order to weed out
pill mills in our state and by being a resource to influence policymakers while making the practice of Interventional Pain
This is not a time for patting ourselves on the back but a sign that GSIPP has and IS making a difference in Georgia.
Please take this opportunity to share this news with your colleagues and friends.
The GSIPP-PAC needs your contributions to keep fighting on behalf of our specialty and all of our patients. Please give generously
as our future depends on it. CLICK HERE to donate to the PAC.
You can find the article here: http://www.acscan.org/content/wp-content/uploads/2014/07/PRC-2013.pdf
Carlos Giron, M.D.
GSIPP Founder and Executive Director
Georgia Prescription Drug Monitoring Program (PDMP) begins allowing access to Rx data
On July 26th, the switch was finally flipped to turn on access to allow practitioners to register and have access to the
Georgia Prescription Drug Marketing Program (PDMP). This means that all practitioners licensed by the Georgia Composite Medical Board
and the Georgia Board of Dentistry who have authority to prescribe or order controlled substances can now register for access the GA PDMP.
For more information for practitioners licensed by the Georgia Composite Medical Board click here
For more information for practitioners licensed by the Georgia Board of Dentistry click here